AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.07 Decreased By ▼ -0.46 (-0.36%)
BOP 6.77 Increased By ▲ 0.09 (1.35%)
CNERGY 4.46 Decreased By ▼ -0.17 (-3.67%)
DCL 8.60 Decreased By ▼ -0.34 (-3.8%)
DFML 40.89 Decreased By ▼ -0.80 (-1.92%)
DGKC 81.00 Decreased By ▼ -2.77 (-3.31%)
FCCL 32.90 Increased By ▲ 0.13 (0.4%)
FFBL 75.00 Decreased By ▼ -0.47 (-0.62%)
FFL 11.68 Increased By ▲ 0.21 (1.83%)
HUBC 109.30 Decreased By ▼ -1.25 (-1.13%)
HUMNL 13.83 Decreased By ▼ -0.73 (-5.01%)
KEL 5.37 Decreased By ▼ -0.02 (-0.37%)
KOSM 7.93 Decreased By ▼ -0.47 (-5.6%)
MLCF 39.03 Decreased By ▼ -0.76 (-1.91%)
NBP 63.75 Increased By ▲ 3.46 (5.74%)
OGDC 196.99 Decreased By ▼ -2.67 (-1.34%)
PAEL 25.90 Decreased By ▼ -0.75 (-2.81%)
PIBTL 7.45 Decreased By ▼ -0.21 (-2.74%)
PPL 155.90 Decreased By ▼ -2.02 (-1.28%)
PRL 26.00 Decreased By ▼ -0.73 (-2.73%)
PTC 17.60 Decreased By ▼ -0.86 (-4.66%)
SEARL 78.90 Decreased By ▼ -3.54 (-4.29%)
TELE 7.84 Decreased By ▼ -0.47 (-5.66%)
TOMCL 33.85 Decreased By ▼ -0.66 (-1.91%)
TPLP 8.54 Decreased By ▼ -0.52 (-5.74%)
TREET 16.68 Decreased By ▼ -0.79 (-4.52%)
TRG 58.29 Decreased By ▼ -3.03 (-4.94%)
UNITY 27.51 Increased By ▲ 0.08 (0.29%)
WTL 1.39 Increased By ▲ 0.01 (0.72%)
BR100 10,490 Increased By 83.2 (0.8%)
BR30 31,358 Decreased By -355.2 (-1.12%)
KSE100 98,026 Increased By 698 (0.72%)
KSE30 30,518 Increased By 325.9 (1.08%)
Technology

Lab-grown blood vessels built from patient’s cells to make dialysis easier

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers a
Published April 1, 2019

Though dialysis is a common treatment for kidney disease, it is still far from pleasant. This is what researchers are trying to change by growing human blood vessels in lab by the patient’s cells in order to make dialysis easier.

Researchers from Humacyte Inc., Duke University and Yale have created lab-grown human blood vessels from the patient’s own cells, which will replace synthetic polymers and donor tissues that carry risks of inflammation and immune system rejection.

The process of dialysis, as per Engadget, mimics some few of the kidney’s main functions, but it requires a machine that pulls out blood from a blood vessel, filters it and pumps it back into the body. An extra blood vessel, either synthetic or donated, is implanted into the patient’s arm that channels blood into the dialysis machine.

Newly created urea sorbent paves way for wearable artificial kidneys

In contrast to usual dialysis, the new method, which is already heading into clinical trials, would allow the patient’s own cells to create the extra blood vessel to be implanted in the arm.

The researchers lined a biodegradable polymer tube with vascular cells from a deceased donor. For eight weeks, the cells multiplied and formed a new tube while the polymer scaffolding broke down. The team then took the cellular tube and implanted it to the patient’s arm. The patients’ cells migrated into the tubes and multiplied to create mature blood vessels.

Out of 60 patients that participated, 13 showed that blood vessels developed into multi-layered tissues that self-healed after injury, effectively becoming like the person’s own blood vessels, reported New Scientist.

Moreover, these bioengineered vessels also showed no signs of scarring or inflammatory reactions. The researchers further hope to create large numbers of engineered blood vessels that doctors can essentially obtain ‘off-the-shelf’ for using in patients with various vascular diseases, including heart disease.

Copyright Business Recorder, 2019

Comments

Comments are closed.